Long-term Safety of Asenapine in Pediatric Patients Diagnosed With Bipolar I Disorder: A 50-Week Open-Label, Flexible-Dose Trial.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 5, p. 367, doi. 10.1007/s40272-016-0184-2
- By:
- Publication type:
- Article
Works matching IS 11745878 AND DT 2016 AND VI 18 AND IP 5
Results: 7
1
2
An Update on the Therapeutic Approach to Vernal Keratoconjunctivitis.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 5, p. 347, doi. 10.1007/s40272-016-0185-1
- By:
- Publication type:
- Article
3
The Cognitive Profile of Ethosuximide in Children.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 5, p. 379, doi. 10.1007/s40272-016-0187-z
- By:
- Publication type:
- Article
4
Improving Outcomes in Infantile Spasms: Role of Pharmacotherapy.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 5, p. 357, doi. 10.1007/s40272-016-0188-y
- By:
- Publication type:
- Article
5
Utility of Octreotide in Advancing Enteral Feeds in Children with Chronic Intestinal Pseudo-Obstruction.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 5, p. 387, doi. 10.1007/s40272-016-0189-x
- By:
- Publication type:
- Article
6
A Mechanism to Explain Ototoxicity in Neonates Exposed to Bumetamide: Lessons to Help Improve Future Product Development in Neonates.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 5, p. 331, doi. 10.1007/s40272-016-0190-4
- By:
- Publication type:
- Article
7
Managing Inflammatory Manifestations in Patients with Chronic Granulomatous Disease.
- Published in:
- Pediatric Drugs, 2016, v. 18, n. 5, p. 335, doi. 10.1007/s40272-016-0182-4
- By:
- Publication type:
- Article